Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesAdherence, compliance key with underinsured
Managed Healthcare Executive, 04/16/09
Walker T - A recent study by IMS Health Inc. reports prescription drug sales in the United States rose 1.3% in 2008 to $291 billion—compared with a 3.8% increase in 2007, about an 8% increase in 2006 and double-digit percentage sales growth in earlier decades. Patients are opting for cheaper generic versions of their prescription drugs or in severe cases, are choosing to go without necessary treatment because they simply cannot afford the medical expenses.
Today in Economics of Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
California to receive federal matching funds for electronic health record incentives program
Centers for Medicare & Medicaid Services Press, 12/18/09
Understanding the Economic Impact of a Pandemic
AMN Healthcare, 12/17/09
HHS Gets Advice on Incentive Definitions
HealthDataManagement, 12/16/09
Sponsor
Article Search
Sponsor
Sponsor